PAR 2.63% 19.5¢ paradigm biopharmaceuticals limited..

PAR Broker Data, page-54

  1. 1,749 Posts.
    lightbulb Created with Sketch. 115
    Ok it doesn't seem reassuring.

    PAR missing some deadlines hasn't helped the share price.

    I don't think it is a sector issue. I hold RHY, EX1 and 4DX and they have performed better than PAR during the period with RHY nearly 2 bagging in the period.

    I don't mean to downramp but they need to get some runs on the board and meet deadlines.

    In the meantime I'll need to spend time doing some research into why this is in a downtrend.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.